Devices › Device types
FDA product code NGT · class 2 · General Hospital
Saline, vascular access flush: medical device reports filed with FDA
3,171 reports carry this product code, 1996–2026; 11 brands with a page.
- 3,171
- reports with this product code
- 0% of all MAUDE reports
- 222
- reports, 12 months to August 2026
- 243 in the 12 months before
- 88%
- classified as malfunction
- 62.3% across all reports
- 0.7%
- classified as death, as reported
- 0.9% across all reports
Product code NGT is FDA's classification for "Saline, vascular access flush" (general Hospital panel), a class 2 device. 3,171 medical device reports carry this product code, 0% of the MAUDE database, from June 1996 to August 2026.
222 reports arrived in the 12 months to August 2026, close to the 243 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (88%), injury (8.8%) and other (2%). 11 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Bd Posiflush Normal Saline Syringe | 495 | 0 | 0% | 97.9% |
| 10 Ml Bd Posiflush Normal Saline Syringe | 213 | 0 | 0% | 99.2% |
| Bd Posiflush Syringe | 155 | 0 | 0.5% | 98.9% |
| Syringe 10ml Saline Fill China Sp | 119 | 21 | 0% | 99.4% |
| Syringe 5ml Saline Fill China Sp | 108 | 23 | 0% | 100% |
| Syringe 10ml Reg Pr Saline 10ml Fill | 100 | 0 | 0% | 98.7% |
| Monoject | 11 | 14 | 0.2% | 88.4% |
| B Braun | 6 | 12 | 3% | 77.8% |
| Unknown Prefill | 4 | 0 | 53.8% | 39.7% |
| Bd | 1 | 0 | 1% | 56% |
| Unspecified Bd Syringe | 1 | 0 | 0.1% | 94.1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Bd Medical Bd West Medical Surgical | 1,459 | 46% |
| Becton Dickinson And | 510 | 16.1% |
| Becton Dickinson | 339 | 10.7% |
| Bd | 51 | 1.6% |
| B Braun Medical | 41 | 1.3% |
| Sistemas Medicos Alaris De C V | 8 | 0.3% |
| Hospira | 6 | 0.2% |
| Becton Dickinson Infusion Therapy Systems | 3 | 0.1% |
| Becton Dickinson Medical Systems | 3 | 0.1% |
| Becton Dickinson De Mexico | 2 | 0.1% |
| Abbott | 1 | 0% |
| Bard Access Systems | 1 | 0% |
| Bd Suzhou | 1 | 0% |
| Becton Dickinson & Bd | 1 | 0% |
| Becton Dickinson & Broken Bow | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Leak/splashthe device leaked | 850 | 26.8% |
| Failure to deliverthe device did not deliver the dose or item | 385 | 12.1% |
| Breakthe device broke | 264 | 8.3% |
| Device contamination with chemical or other material | 192 | 6.1% |
| Device markings/labelling problema problem with the device markings or label | 135 | 4.3% |
| Physical resistance/sticking | 123 | 3.9% |
| Packaging problem | 116 | 3.7% |
| Defective component | 81 | 2.6% |
| Contamination | 80 | 2.5% |
| Material separation | 70 | 2.2% |
| Crackthe device cracked | 66 | 2.1% |
| Microbial contamination of device | 66 | 2.1% |
| Fluid/blood leak | 59 | 1.9% |
| Nonstandard device | 47 | 1.5% |
| Material discolored | 40 | 1.3% |
| Volume accuracy problem | 40 | 1.3% |
| Short fill | 39 | 1.2% |
| Device damaged prior to usethe device was damaged before use | 37 | 1.2% |
| Insufficient device problem information | 37 | 1.2% |
| Material deformation | 37 | 1.2% |
Questions about saline, vascular access flush reports
What is product code NGT?
FDA's classification code for "Saline, vascular access flush", class 2, reviewed by the general Hospital panel. Every device report carries the product code of the device involved.
How many reports carry this code?
3,171 reports through August 2026, 222 of them in the latest 12 months.
Which brands appear most often?
Bd Posiflush Normal Saline Syringe (495), 10 Ml Bd Posiflush Normal Saline Syringe (213), Bd Posiflush Syringe (155), Syringe 10ml Saline Fill China Sp (119) and Syringe 5ml Saline Fill China Sp (108). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.